CompuGroup Current Deferred Revenue from 2010 to 2024
| 0MSD Stock | 14.81 0.56 3.93% |
Current Deferred Revenue | First Reported 2009-12-31 | Previous Quarter 275.6 M | Current Value 130.1 M | Quarterly Volatility 61.3 M |
Check CompuGroup Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CompuGroup Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 121.6 M, Interest Expense of 25.5 M or Selling And Marketing Expenses of 10.9 M, as well as many indicators such as . CompuGroup financial statements analysis is a perfect complement when working with CompuGroup Medical Valuation or Volatility modules.
CompuGroup | Current Deferred Revenue |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CompuGroup Stock Analysis
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.